REGAN GARDNER: Open Payments
NPI 1659960078 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,428 in 113 payments from 12 companies in 2025. Trend: 2023 $36 · 2024 $1,089 · 2025 $2,428
Food & beverage: $2,261Education: $167
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 27 | $652 |
| Arcutis Biotherapeutics, Inc. | 12 | $347 |
| Amgen Inc. | 8 | $316 |
| ABBVIE INC. | 15 | $276 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $233 |
| Regeneron Healthcare Solutions, Inc. | 10 | $188 |
| Galderma Laboratories, L.P. | 21 | $186 |
| Lilly USA, LLC | 4 | $79 |
| UCB, Inc. | 3 | $77 |
| Incyte Corporation | 1 | $28 |
Products named: TREMFYA, Zoryve, Otezla, DUPIXENT, NEMLUVIO, SKYRIZI, ILUMYA, RINVOQ.
Industry payments across VA — which companies pay providers there.
